Zhejiang Gongdong Medical Technology Co., Ltd. (SHA:605369)
19.04
+0.37 (1.98%)
Apr 29, 2026, 3:00 PM CST
SHA:605369 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 55.96 | 51.38 | 171.63 | 109.13 | 326.04 | 310.99 | Upgrade
|
| Depreciation & Amortization | 100.26 | 100.26 | 93.04 | 83.99 | 41.23 | 21.81 | Upgrade
|
| Other Amortization | 2.72 | 2.72 | 2.49 | 1.73 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.04 | 0.04 | 0.02 | 0.01 | 0.1 | -9.96 | Upgrade
|
| Asset Writedown & Restructuring Costs | 35.07 | 35.07 | 1.24 | 2.6 | 1.48 | 10.43 | Upgrade
|
| Loss (Gain) From Sale of Investments | 11.88 | 11.88 | -11.48 | -6.5 | 0.62 | -4.65 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 4.52 | -0.35 | 2.61 | - | Upgrade
|
| Other Operating Activities | 44.07 | 17.86 | -0.58 | 10.37 | -22.65 | 5.48 | Upgrade
|
| Change in Accounts Receivable | 5.52 | 5.52 | -37.36 | -4.36 | -53.49 | -45.66 | Upgrade
|
| Change in Inventory | -5.07 | -5.07 | -21.61 | 3.75 | -12.03 | -51.69 | Upgrade
|
| Change in Accounts Payable | 38.54 | 38.54 | 10.16 | -19.06 | -22.7 | 117.54 | Upgrade
|
| Change in Other Net Operating Assets | 2.37 | 2.37 | 1.47 | 2.88 | 19.92 | 13.41 | Upgrade
|
| Operating Cash Flow | 284.75 | 253.96 | 210.38 | 185.39 | 282.75 | 372.99 | Upgrade
|
| Operating Cash Flow Growth | 49.97% | 20.71% | 13.48% | -34.43% | -24.19% | 54.01% | Upgrade
|
| Capital Expenditures | -115.95 | -111.6 | -109.61 | -121.82 | -172.18 | -275.56 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.19 | 0.19 | 0 | 0.01 | 0.05 | 11.85 | Upgrade
|
| Cash Acquisitions | -6.85 | -18.98 | -5.36 | -275.58 | - | - | Upgrade
|
| Investment in Securities | 21 | 49.81 | -87.86 | -0.17 | 49.21 | -45 | Upgrade
|
| Other Investing Activities | -0.31 | - | 7.3 | 0.14 | -40.18 | -7.98 | Upgrade
|
| Investing Cash Flow | -101.91 | -80.59 | -195.53 | -397.43 | -163.1 | -316.69 | Upgrade
|
| Short-Term Debt Issued | - | - | 60 | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | 245 | - | - | - | - | Upgrade
|
| Total Debt Issued | 305 | 245 | 60 | - | - | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -60 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -120 | -8.63 | -0.59 | -0.69 | -0.35 | Upgrade
|
| Total Debt Repaid | -180 | -120 | -68.63 | -0.59 | -0.69 | -0.35 | Upgrade
|
| Net Debt Issued (Repaid) | 125 | 125 | -8.63 | -0.59 | -0.69 | -0.35 | Upgrade
|
| Issuance of Common Stock | 14.63 | 14.63 | - | - | 1.68 | 30.87 | Upgrade
|
| Repurchase of Common Stock | - | - | -38.88 | -5.12 | -0.69 | - | Upgrade
|
| Common Dividends Paid | -66.35 | -65.68 | -81.23 | -90.1 | -155.43 | -144 | Upgrade
|
| Other Financing Activities | -20.11 | -8.71 | 10.5 | - | - | - | Upgrade
|
| Financing Cash Flow | 53.16 | 65.24 | -118.23 | -95.8 | -155.13 | -113.47 | Upgrade
|
| Foreign Exchange Rate Adjustments | -22.87 | -13.94 | 8.9 | 2.28 | 30.88 | -5.76 | Upgrade
|
| Net Cash Flow | 213.13 | 224.67 | -94.49 | -305.56 | -4.59 | -62.94 | Upgrade
|
| Free Cash Flow | 168.8 | 142.35 | 100.77 | 63.57 | 110.57 | 97.43 | Upgrade
|
| Free Cash Flow Growth | 189.62% | 41.26% | 58.53% | -42.51% | 13.49% | -27.08% | Upgrade
|
| Free Cash Flow Margin | 14.55% | 12.53% | 9.04% | 6.52% | 7.53% | 8.16% | Upgrade
|
| Free Cash Flow Per Share | 0.77 | 0.64 | 0.46 | 0.29 | 0.50 | 0.44 | Upgrade
|
| Cash Income Tax Paid | 26.95 | 27 | 29.63 | 20.31 | 98.04 | 82.59 | Upgrade
|
| Levered Free Cash Flow | 175.89 | 100.18 | 23.44 | -41.45 | 5.51 | 7.15 | Upgrade
|
| Unlevered Free Cash Flow | 175.89 | 100.18 | 25.23 | -40.55 | 5.53 | 7.17 | Upgrade
|
| Change in Working Capital | 34.75 | 34.75 | -50.5 | -15.57 | -66.69 | 38.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.